< Back to previous page
Researcher
Pieter Gillard
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 2009 → Today
Projects
1 - 10 of 10
- Technological improvements in the management of type 1 diabetesFrom1 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The road to personalized management of type 1 diabetes with a focus on closed-loop devicesFrom2 Aug 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The use of novel technologies with a focus on the individual needs of people living with type 1 diabetesFrom1 Oct 2020 → 30 Sep 2021Funding: BOF - postdoctoral mandates
- Closed-loop insulin delivery in pregnant women with type 1 diabetes (the CRISTAL study)From1 Oct 2020 → TodayFunding: FWO Strategic Basic Research Grant, BOF - doctoral mandates
- Exploring the use of continuous glucose monitoring to improve glycemic control and quality of life in type 1 diabetesFrom1 Jan 2019 → 31 Mar 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Histology: a vital tool for endocrine and metabolic researchFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- Identification of patient-specific parameters for bolus calculators in type 1 diabetic patientsFrom15 Aug 2016 → 31 Dec 2020Funding: FWO Strategic Basic Research Grant
- Robust identification of patient-specific parameters for bolus calculators in type 1 diabetic patientsFrom1 Oct 2015 → 30 Sep 2017Funding: IOF - Industrial Research Fund
- The beta-cell and the immune system in type 1 diabetes: partners in crime - developing new therapies in type 1 diabetes through better understanding of beta-cell behaviour and use of novel immunomodulators.From1 Oct 2013 → 30 Sep 2018Funding: BOF - Concerted Research Project from 1994
- Relation between residual beta cell function and glycemic variability in (pre)type 1 diabetes.From1 Jan 2011 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 116
- Formation of amyloid in encapsulated human pancreatic and human stem cell-generated beta cell implants(2021)
Authors: Pieter Gillard
Pages: 2090 - 2099 - Insulitis and lymphoid structures in the islets of Langerhans of a 66-year-old patient with long-standing type 1 diabetes(2021)
Authors: Pieter Gillard
Pages: 1209 - 1214 - Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter](2021)
Authors: Pieter Gillard, Chantal Mathieu
Pages: 935 - 938 - Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting With Continuous Glucose Monitoring: FUTURE-PEAK(2021)
Authors: Sara Charleer, Chantal Mathieu, Pieter Gillard
Pages: E3037 - E3048 - A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes(2021)
Authors: Pieter Gillard, Chantal Mathieu
Pages: 313 - 324 - Diabetes type 1 en sport: proof-of-concept dashboard(2020)
Authors: Erika Vanhauwaert, Sara Charleer, Pieter Gillard
Pages: 26 - 29 - The impact of continuous glucose monitoring for people with type 1 diabetes: A focus on everyday life(2020)
Authors: Sara Charleer, Pieter Gillard, Chantal Mathieu
- Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study(2020)
Authors: Sara Charleer, Chantal Mathieu, Pieter Gillard
Pages: 3016 - 3023 - Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increasedHbA1cand weight in well-controlled youth with type 1 diabetes(2020)
Authors: Sara Charleer, Pieter Gillard, Chantal Mathieu, Kristina Casteels
Pages: 1465 - 1474 - The nephrological perspective on SGLT-2 inhibitors in type 1 diabetes(2020)
Authors: Pieter Gillard